Doubts emerge over deal to buy Wyeth 9225/343

据 wsj jan 27,2009 报导. Pfizer Inc.hailed its planned $68 billion takeover of rival Wyeth as an ideal combination,but analysts say the deal will only partially solve some of the New York drug giant's long-term problems. 该文还列出世界上销售量前面的15家药公司,并讲到其他公司对前述事件的意见.